Skip to main content
Aadi Bioscience, Inc. (AADI)
NASDAQ: AADI · IEX Real-Time Price · USD
1.750
+0.070 (4.17%)
At close: Apr 26, 2024, 4:00 PM
1.749
-0.001 (-0.06%)
After-hours: Apr 26, 2024, 4:37 PM EDT

Aadi Bioscience Revenue

In the year 2023, Aadi Bioscience had annual revenue of $24.35M with 60.06% growth. Revenue in the quarter ending December 31, 2023 was $6.33M with 21.03% year-over-year growth.

Revenue (ttm)
$24.35M
Revenue Growth
+60.06%
P/S Ratio
1.76
Revenue / Employee
$273,640
Employees
89
Market Cap
42.97M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202324.35M9.14M60.06%
Dec 31, 202215.22M14.10M1,258.57%
Dec 31, 20211.12M-13.46M-92.32%
Dec 31, 202014.58M--
Dec 31, 20190--
Dec 31, 201820.16M--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
American Oncology Network 1.28B
Cutera 230.18M
Rapid Micro Biosystems 22.52M
ReWalk Robotics 13.85M
Aspira Women's Health 9.15M
Dyadic International 2.90M
Renalytix 2.41M
Revenue Rankings

AADI News

More News